FDA Warning Letter — Kelley-Ross & Associates, Inc. dba Kelley-Ross Compounding Pharmacy
The FDA took a Warning Letter action against Kelley-Ross & Associates, Inc. dba Kelley-Ross Compounding Pharmacy on August 2, 2018 (Seattle, WA). The action was issued by CDER and concerns drugs products. This facility has 2 recent FDA inspections on record.
Action Details
- Facility
- Kelley-Ross & Associates, Inc. dba Kelley-Ross Compounding Pharmacy
- Date
- August 2, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Center
- CDER
- Location
- Seattle, WA (United States)